Pfizer’s gene therapy for rare genetic bleeding disorder succeeds in late-stage trial

by | Jul 24, 2024 | Consumer Products, FEATURED, HEADLINE, Investing, Stocks

Pfizer on Wednesday said its experimental gene therapy for a rare genetic blood-clotting disorder succeeded in a large late-stage trial, paving the …

FEATURED